Among patients with PD-1/PD-L1-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), treatment with ...

Breast cancer survivors highlighted guidance and encouragement they received when first diagnosed, offering reassurance for ...

Among patients with operable, newly diagnosed brain metastases, treatment with GammaTile was associated with a greater than 50% reduction in the risk of either tumor recurrence or death compared to ...

VCN-01 plus standard chemotherapy and Abraxane proved safe and effective for patients with metastatic pancreatic cancer.

ADC usage in breast cancer treatment increased 3.7-fold from 2021 to 2023, with significant reductions in median time to ...

Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic ...

The cancer vaccine IO102-IO103 plus Keytruda was associated with a clinically relevant improvement in median progression-free ...

Cancer treatments have evolved, improving survival rates and quality of life, challenging the notion of cancer as a death ...

Trodelvy plus Keytruda may maintain QOL and delay physical decline in PD-L1-positive mTNBC patients. The combination therapy showed improved progression-free survival and reduced symptom burden ...

Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...

Ivonescimab combined with chemotherapy significantly improved progression-free survival (PFS) compared with Tevimbra ...

The DUO-O trial showed significant improvement in progression-free survival with Imfinzi, Avastin, and Lynparza, but no ...